Saturday, November 22, 2014
Print Current Session:
|
|
Saturday
SESSION 109:
CLASSIFICATION, IMAGING, AND EMBOLIC AGENTS FOR VASCULAR ANOMALIES
|
|
SESSION 109 SCHEDULE | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
8:00 AM - 8:10 AM | Current Classification And Nomenclature Of Vascular Malformations |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
View Abstract | |
8:10 AM - 8:20 AM | Vascular Tumors Confused With Vascular Malformations: Pediatric Hemangioma, RICH, NICH, KPH Of Liver, KPH Of Trunk With Kassabach-Merritt Syndrome |
Presenter(s):Francine Blei, MD, MBA | |
View Abstract | |
8:20 AM - 8:30 AM | New Imaging Modalities Essential For Accurate Diagnosis Of Vascular Malformations |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
8:30 AM - 8:40 AM | 2014 ISSVA Classification Of Vascular Anomalies: Update |
Presenter(s):Francine Blei, MD, MBA | |
View Abstract | |
8:40 AM - 8:50 AM | Techniques For Treating Vascular Malformations Of The Extremities |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
8:50 AM - 9:00 PM | Old Things About Arterio-Venous Lesions And Personal Classification |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
9:00 AM - 9:10 AM | The Houdart AVM Classification, The Cho-Do AVM Classification, And The Yakes AVM Classification And Its Therapeutic Implications |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
9:10 AM - 9:20 AM | Use Of Polymerizing Agents In The Endovascular Treatments Of AVMs |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
9:20 AM - 9:30 AM | Onyx AVM Embolotherapy: The Histologic Tissue Changes, The Tissue Inflammatory Response, And The Fluoroscopy Issues With Its Use |
Presenter(s):Mollie Meek, MD | |
View Abstract | |
9:30 AM - 9:40 AM | Sclerogel: A New Ethanol Based Embolic Agent To Treat Low-Flow Vascular Malformations |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
9:40 AM - 10:00 AM | Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 109 | |
previous | next |